Brown Advisory Inc Teva Pharmaceutical Industries LTD Transaction History

Brown Advisory Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$8.12 - $15.72 $690,110 - $1.34 Million	-84,989 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$15.58 - $20.01 $546,250 - $701,570	35,061 Added 70.22%	84,989 $1.33 Million
Q4 2018 Feb 13, 2019	SELL	$14.59 - $23.84 $10,636 - $17,379	-729 Reduced 1.44%	49,928 $770,000
Q3 2018 Nov 13, 2018	BUY	$21.06 - $25.65 $1.07 Million - $1.3 Million	50,657 New	50,657 $1.09 Million
Q4 2017 Feb 12, 2018	SELL	$11.23 - $19.1 $850,245 - $1.45 Million	-75,712 Closed	0 $0
Q3 2017 Nov 13, 2017	SELL	$15.41 - $32.17 $46.3 Million - $96.7 Million	-3,005,966 Reduced 97.54%	75,712 $1.33 Million
Q2 2017 Aug 14, 2017	BUY	N/A	3,081,678	3,081,678 $102 Million

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

Stay updated on Brown Advisory Inc with notifications on news.